A retrospective case study of sunitinib treatment in three patients with Von Hippel-Lindau disease

Von Hippel-Landau (VHL) disease is characterized by malignant and benign tumors in multiple organs. Sunitinib, a tyrosine kinase inhibitor, has been clinically available for treating sporadic patients with recurrent or unresectable and metastatic clear renal cell carcinomas (cRCCs) and metastatic le...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Cancer Biol Ther
मुख्य लेखकों: Yuan, Gang, Liu, Qiuli, Tong, Dali, Liu, Gaolei, Yi, Yuting, Zhang, Jun, Zhang, Yao, Wang, Lin-ang, Wang, Luofu, Chen, Rongrong, Guan, Yanfang, Yi, Xin, Lan, Weihua, Jiang, Jun
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Taylor & Francis 2018
विषय:
Clinical Case Report
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6154838/
https://ncbi.nlm.nih.gov/pubmed/29947576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1470732
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन